Company filings profile · CIK 0001818794
Dyne Therapeutics, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Dyne Therapeutics, Inc. (DYN): 41 filings in the last 90 days vs 106 in the prior 90 (filing-velocity cooling ↓ · 0.39×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 30, 2026. Source-linked, daily-refreshed.
Material 8-K events — Dyne Therapeutics, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 29, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Jul 29, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 22, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Jul 20, 2026 | Other Events | ↗ |
Watch Dyne Therapeutics, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 29, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 8, 2026 | 144 | ↗ | |
| Sep 8, 2026 | 144 | ↗ | |
| Sep 8, 2026 | 4 | 4 | ↗ |
| Sep 8, 2026 | 4 | 4 | ↗ |
| Sep 8, 2026 | 4 | 4 | ↗ |
| Sep 4, 2026 | 144 | ↗ | |
| Aug 17, 2026 | 4 | ↗ | |
| Aug 17, 2026 | 4 | 4 | ↗ |
| Aug 17, 2026 | 4 | 4 | ↗ |
| Aug 17, 2026 | 4 | 4 | ↗ |
| Aug 17, 2026 | 4 | 4 | ↗ |
| Aug 14, 2026 | 144 | ↗ | |
| Aug 14, 2026 | 144 | ↗ | |
| Aug 14, 2026 | 144 | ↗ | |
| Aug 13, 2026 | 144 | ↗ | |
| Aug 13, 2026 | 144 | ↗ | |
| Aug 13, 2026 | 144 | ↗ | |
| Aug 13, 2026 | 144 | ↗ | |
| Aug 13, 2026 | 144 | ↗ | |
| Aug 13, 2026 | 144 | ↗ | |
| Aug 13, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 13, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 6, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 29, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 29, 2026 | 4 | 4 | ↗ |
| Jul 29, 2026 | 10-Q | 10-Q | ↗ |
| Jul 28, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 27, 2026 | 144 | ↗ | |
| Jul 22, 2026 | 424B5 | 424B5 | ↗ |
| Jul 22, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Jul 21, 2026 | 424B5 | 424B5 | ↗ |
| Jul 20, 2026 | 8-K | Other Events | ↗ |
| Jul 8, 2026 | 4 | ↗ | |
| Jul 7, 2026 | 144 | ↗ | |
| Jul 7, 2026 | 144 | ↗ | |
| Jul 7, 2026 | 144 | ↗ | |
| Jul 7, 2026 | 144 | ↗ | |
| Jul 6, 2026 | 144 | ↗ | |
| Jul 6, 2026 | 144 | ↗ |